Arrowhead Research Nabs Alvos for Cancer-Homing Peptides
Firm will couple technology with its siRNA delivery tools and small molecules. Arrowhead Research is acquiring Alvos Therapeutics (formerly known as Mercator Therapeutics), which is leveraging an in vivo phage…
Read guide →